Their epigenetic analysis revealed methylation of a CpG island in the 5′-regulatory region of Spry4 in more than a half of all prostate cancer DNA samples studied which was significantly correlated with decreased expression of Spry4 mRNA. The gene discussed is SPRY4; the disease is prostate carcinoma.